Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
Date:3/12/2008

Restructured majority of convertible notes due June 2008

Reduced net operating expenses going forward

Projects Zevalin(R) net sales revenues of $15 million in 2008

SEATTLE, March 13 /PRNewswire-FirstCall/ -- Seattle-Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) today reported recent accomplishments and financial results for the quarter and twelve months ended December 31, 2007.

Recent Events

Announced completion of Zevalin(R) (Ibritumomab Tiuxetan) acquisition from Biogen Idec for an upfront payment of $10.1 million and initiated building Zevalin sales, marketing, and medical affairs infrastructure

Raised $14.8 million in aggregate gross proceeds through the issuance of common and preferred stock and warrants; raised $51.7 million in an offering of 9% Senior Convertible Notes due 2012; of which $16.2 million was used to induce the conversion of $21.5 million of outstanding Series A,B,C, and D convertible preferred securities to common stock

Restructured approximately 81 percent of the convertible notes due in June 2008, reducing total due in 2008 from $55.9 million to $10.7 million

Reduced expected net operating expenses by 35%, targeting $77 million in net cash operating expenses in 2008, by focusing resources on reaching $15 million in net Zevalin revenues, pursuing European marketing authorization (MAA) for XYOTAX (paclitaxel poliglumex, CT-2103), preparing for a potential U.S. marketing application (NDA) for pixantrone (BBR 2778) in 2009, and supporting the advancement of brostallicin

"Now that we have made significant progress on our strategy of simplifying our capital structure, reducing operating expenses, and shifting our resources to near-term o
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
2. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
3. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
4. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
5. Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
6. Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
7. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
8. Cell Therapeutics, Inc. Announces $6.5 Million Offering
9. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
10. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
11. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... FRIDAY, May 17 (HealthDay News) -- As the American ... considered the "bible" of modern psychiatry this weekend, the ... unprecedented, the amount of commentary and debate and criticism," ... Association (APA). "It,s been an interesting phenomenon, but the ... it and then make your own determination of how ...
(Date:5/18/2013)... May 18 (HealthDay News) -- Children who swallow high-powered ... remove the objects, according to a new study. ... in New Orleans, found that more than 79 percent ... either surgery or an endoscopic procedure, in which a ... tract. Only 21 percent of these cases can be ...
(Date:5/18/2013)... News) -- Just a few extra cups of coffee ... autoimmune liver disease known as primary sclerosing cholangitis (PSC), ... Clinic in Rochester, Minn., found that drinking coffee was ... which can lead to cirrhosis of the liver, liver ... prove a cause-and-effect relationship. "While rare, PSC ...
(Date:5/18/2013)... 18, 2013 MOOSGO.COM published an original art ... book features a group of artists who share their creations ... illustrations and paintings. Exclusively for iPad . , ... songs and videos that reflect the signature idiosyncrasy and passion ... the Apple iBook Store and it includes a free ...
(Date:5/18/2013)... FL (May 18, 2013) The use of ... a colonoscopy, according to new research presented today ... which begins days in advance of the procedure, ... medication to be taken at strict intervals. The ... doctors to see cancer and precancerous polyps in ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New Art Book for iPad: Tango Art 2Health News:New smartphone application improves colonoscopy preparation 2
... the first time, there is reason to believe that a ... -- which triggers growth of new blood vessels in hearts ... viable new option for thousands of patients suffering with heart ... range from drugs to surgical procedures that open blocked arteries ...
... doctors has found that aspirin works just as well as ... suspected that Warfarin was more effective but that aspirin was ... are equals in both respects. ,Both drugs slow ... the final stages of the most common type of stroke ...
... retrovirus that binds to receptors found on membranes of immune ... is internalized, copied into DNA, then migrates into the nucleus ... In many cases, the inserted viral genes remain dormant, sometimes ... Acquired Immune Deficiency Syndrome is a collection of 26 clinical ...
... implants in a woman's uterus, the more likely she is ... the latest New England Journal of Medicine details the most ... of pregnancy - influences its success or failure. ,Fertilised ... anywhere from six to 12 days after ovulation, the researchers ...
... children into learning too much too soon is more ... nursery experts. This setting of targets for three to ... as tantrums and bed-wetting, rather than achieve accelerated learning, ... are often intimidated by an early start to their ...
... asthma risks,say the researchers.Traditional student digs with mouldy and ... researchers. ,A study of over 20,000 Finnish students found ... risk of asthma, but left residents with a greater ... in damp houses were found to need more antibiotics ...
Cached Medicine News:Health News:More about HIV 2Health News:More about HIV 3
(Date:5/18/2013)... Fla. , May 18, 2013 Although ... and are considered the most sensitive method for detecting ... effective in preventing cancer cases 3 . EndoChoice ® ... new Fuse™ system significantly improves the accuracy of this ... by colonoscopists. EndoChoice will be discussing these clinical trial ...
(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...
(Date:5/18/2013)... 18, 2013 Faruqi & Faruqi, LLP, ... potential securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation ... violated federal securities laws by issuing materially false ... drug trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
... , July 19, 2010 Today, Novo Nordisk announced the,landmark recruitment of ... effects of modern insulins in,the management of type 2 diabetes.[1] , ... Spanning 28 countries across 4 continents and involving ... therapy. , , , ...
... Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are ... Focused Ultrasound, scheduled for October 17 through 20 near ... , , ... edge preclinical, translational and clinical research related to one of today,s ...
Cached Medicine Technology:World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3MR-Guided Focused Ultrasound Symposium Announces Sponsors 2MR-Guided Focused Ultrasound Symposium Announces Sponsors 3
... include painful arthritic deformity of the ... subtalar joint, failed fusion of the ... plafond and/or talus where reconstruction is ... joint combined with severe arthritic changes ...
... Ankle System from DePuy is the first ... base of support that bridges the fused ... force distribution. The Agility Ankle, developed in ... to allow for normal alignment during the ...
... Addressing the key clinical and economic ... Grip1 System is designed to maximize tension ... site. The system combines efficient instrumentation with ... Cable Grip system is indicated for general ...
... first multi-filament orthopaedic cable, Dall-Miles™, was ... means of providing superior fixation over ... Today, with more than 100 published ... Dall-Miles™ Cable System continues to set ...
Medicine Products: